Send Message
caojing@oryzogen.com
Request A Quote|
Home News

Announcement of Removal

All Products
Recombinant Human Albumin (37)
Recombinant HSA (37)
Proteinase K (34)
Recombinant Fibronectin (13)
bFGF Growth Factor (20)
Recombinant IGF 1 Long R3 (10)
Recombinant Human Lactoferrin (13)
Recombinant Protein Service (5)
Epidermal Growth Factor (20)
Albumin Skin Care (10)
Recombinant VEGF (2)
Recombinant Lysozyme (4)
Cosmetic Ingredients (35)
Certification
China Wuhan Healthgen Biotechnology Corp. certification
China Wuhan Healthgen Biotechnology Corp. certification
Customer Reviews
Awesome company, highly recommended for Healthgen Biotech updates.

—— David Castillo

Healthgen Biotech has always been committed to science and scientists. Hope you will do well in new field too.

—— Frank Schauer

I'm Online Chat Now
Company News
Announcement of Removal

Your esteemed costomers and related units:
Owing to the development of the company, we have removed to Level 1, B6, Biolake on May,2011. Hereon, thanks for your long-term attention and support. We will also continue to provide you products of higher quality and more perfect services.


New address:No.666 Gaoxin Avenue,East Lake Development Zone, Wuhan, China
Tel: 027-87570660/87570601/87510670

human serum albumin

Pub Time : 2021-07-21 09:30:35 >> News list
Contact Details
Wuhan Healthgen Biotechnology Corp.

Contact Person: Ms. Abby

Tel: +86-15071115810

Fax: 86-27-59403933-59416006

Send your inquiry directly to us (0 / 3000)

NEWS
china latest news about Phase II clinical study of plant-derived recombinant human serum albumin achieved phased results

Phase II clinical study of plant-derived recombinant human serum albumin achieved phased results

china latest news about Healthgen Biotech won the "Gold Award of the 2nd High-value Patent Competition of Hubei Province "

Healthgen Biotech won the "Gold Award of the 2nd High-value Patent Competition of Hubei Province "

china latest news about The world's first recombinant protein drug for the treatment of emphysema has been approved by the US FDA for clinical research

The world's first recombinant protein drug for the treatment of emphysema has been approved by the US FDA for clinical research

CONTACT US
Factory Address:268 Shendun 5th Road, East Lake High-Tech Development Zone, Wuhan, China 430020
Sales office:268 Shendun 5th Road, East Lake High-Tech Development Zone, Wuhan, China 430020
+86-27-59301891-8015
caojing@oryzogen.com
LEAVE MESSAGE

Privacy Policy | China Recombinant Human Albumin 274-272-6 Supplier. Copyright © 2021 - 2025 recombinant-hsa.com. All Rights Reserved. Developed by ECER